Sponsored Host cell protein analysis using mass spectrometry can identify a wider range of HCPs without the need for specialized antibody reagents or product- or process-specific method development.
Sponsored Antibody-drug conjugates (ADCs) add an additional level of challenge to testing of biotherapeutics. Characterization of new innovators and biosimilarity assessment is more challenging than for antibody therapeutics.
Don’t Just Pass the Baton: Comprehensive Capabilities and Parallel Processes Accelerate Biologic Development TimelinesSponsored In this webinar series, three biologics subject matter experts will discuss critical considerations in their respective parallel processes: drug substance, drug product and clinical supply.
Sponsored In this webinar Jason Chiu from JSR Life Sciences presents the new Chromassette technology that enables high flow-rates for any type of resin regardless of bead rigidity or bed volume